Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600332.SS

BUYGet insider-trade alerts

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited · Healthcare · China · $4.7B · Avg Vol: $27M/d

75
StockRank
Q
50
V
69
M
48
P/E (TTM)
10.9x
ROE
7.4%
D/E
0.4x
Dividend %
4.2%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a major healthcare conglomerate engaged in pharmaceutical manufacturing, medical distribution, and consumer health products. The company owns iconic consumer brands like Wanglaoji herbal tea alongside a dominant medical distribution network in Southern China. It is a highly defensive, state-owned enterprise characterized by its dual-engine growth in pharmaceuticals and consumer staples.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue10.4B11.1B11.0B11.4B3.1%11.6B12.0B12.5B4.7%
EPS0.360.370.260.27-9.1%0.27———
Shares1.6B1.6B1.6B1.6B0.0%1.4B———
Debt1.7B1.8B2.0B2.3B10.2%2.7B———
Equity4.7B5.1B5.3B5.6B5.6%————
Op CF1.0B604.4M507.0M-34.2M-29.9%213.1M———
Inv CF-1.1B-458.8M-878.4M-590.2M—————
Fin CF6.8M-291.3M-148.2M72.1M—————
Loading 1Y...
PRICE (1Y)+0.1%
2.933.013.083.153.22May 25Jun 15Jul 6
SMA 50SMA 200
Close
$3.17
RSI (14)
52.2
52W High
$3.97
From 52W High
0.8%

SCORE BREAKDOWN

Quality
50
ROIC
9.0%70.4
ROE
7.4%63.7
GP/Assets
15.0%35.8
Op. Margin
9.3%64.3
FCF/Assets
-1.7%39.9
Piotroski
549.0
Int. Cover
10.2x60.6
D/E Ratio
0.44x35.1
Current Ratio
1.60x28.7
Value
69
P/E (TTM)
10.9x85.6
EV/EBITDA
10.5x63.6
P/FCF
—N/A
P/B
0.8x87.6
P/S
0.4x93.5
Div Yield
4.2%83.8
Momentum
48
52W High %
80%65.6
RS 6M
-20%45.6
SMA 50/200
0.89x36.0
EPS Rev 4W
+0.1%64.1
EPS Rev 12W
—N/A
EPS Improve
+11%27.0
Q Growth
-2%38.0

FUNDAMENTALS

Market Cap
$4.7B
P/E (Forward)
9.9x
Gross Margin
16.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600332.SS are excluded.

TickerCompanyMkt CapStockRankSignal
600332.SSGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited(you)$4.7B75BUY
600998.SSJointown Pharmaceutical Group Co., Ltd$3.4B80BUY
600056.SSChina Meheco Group Co., Ltd.$1.9B80BUY
2607.HKShanghai Pharmaceuticals Holding Co., Ltd$5.5B97STRONG BUY
1099.HKSinopharm Group Co. Ltd.$6.3B96STRONG BUY
600511.SSChina National Medicines Corporation Ltd.$2.9B98STRONG BUY
600739.SSLiaoning Cheng Da Co., Ltd.$2.2B56HOLD
301015.SZQingdao Baheal Medical INC.$1.5B86STRONG BUY
000028.SZChina National Accord Medicines Corporation Ltd.$1.7B96STRONG BUY
000950.SZC.Q. Pharmaceutical Holding Co., Ltd.$1.3B51HOLD

Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) — Stock Score Summary

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) has a MoatMap StockRank of 75/100 based on Quality (50/100), Value (69/100), and Momentum (48/100) factor scores. The current signal is BUY.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a major healthcare conglomerate engaged in pharmaceutical manufacturing, medical distribution, and consumer health products. The company owns iconic consumer brands like Wanglaoji herbal tea alongside a dominant medical distribution network in Southern China. It is a highly defensive, state-owned enterprise characterized by its dual-engine growth in pharmaceuticals and consumer staples.

Key Financial Metrics

Price$3.17
Market Cap$4.7B
P/E (TTM)10.92
P/E (Forward)9.88
Price/Book0.81
Return on Equity7.4%
Return on Invested Capital9.0%
Debt/Equity44.04
Gross Margin16.1%
Operating Margin9.3%
Revenue Growth3.6%
Dividend Yield4.2%
Free Cash Flow$-217M

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the Medical Distribution industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s (600332.SS) StockRank?
MoatMap’s StockRank for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) is 75/100, with a Buy signal. It is a composite of Quality (50), Value (69), and Momentum (48) factor ranks across MoatMap’s 20,000+ stock universe.
Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited have an economic moat?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited a buy, hold, or sell?
MoatMap’s current signal for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) is Buy, based on a StockRank of 75/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) operates in the Healthcare sector, specifically the Medical Distribution industry (China).
Browse all ranked stocks600332.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock